HomeInvestingEarningsJohnson & Johnson (JNJ) Shockwave Deal & Earnings Takeaways

Johnson & Johnson (JNJ) Shockwave Deal & Earnings Takeaways

CFRA views the newly announced $13.1B Johnson & Johnson (JNJ) shockwave deal as positive. David Toung and Sel Hardy discuss the takeaways from Johnson & Johnson’s earnings. The CFRA analyst also notes that they think shares have been under pressure to news that its cough syrup has to be recalled in several African countries. Tune in to find out more about the stock market today.

Trading 360

16 Apr 2024

SHARE

ON AIR
education
4:30 pm
Your First Trade
replay
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
education
7:00 am
Inside the Mind of a Trader
REPLAY
education
7:30 am
Inside the Mind of a Trader
REPLAY
education
8:00 am
Inside the Mind of a Trader
REPLAY
8:30 am
Market Overtime
REPLAY
9:00 am
Gamma On
REPLAY
9:30 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
10:30 am
Gamma On
REPLAY
11:30 am
Gamma On
REPLAY
12:00 pm
Gamma On
REPLAY
12:30 pm
Gamma On
REPLAY
1:00 pm
Gamma On
REPLAY
2:00 pm
Gamma On
REPLAY
3:00 pm
Gamma On
REPLAY
education
4:00 pm
Your First Trade
REPLAY
ON AIR
education
4:30 pm
Your First Trade
REPLAY
education
5:00 pm
Your First Trade
REPLAY
education
5:30 pm
Your First Trade
REPLAY
education
6:00 pm
Your First Trade
REPLAY
6:30 pm
Market Overtime
REPLAY
7:00 pm
Gamma On
REPLAY
8:00 pm
Gamma On
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY

Get the Market Minute

Daily insights for every investor